companydata.dkcompanydata.dk

JENARK A/S: Financial statements 2024

CVR: 13237476

Source: annual report 2024, Danish Business Authority

01/10/2023 – 30/09/2024

JENARK A/S (CVR 13237476) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,394,727 and a net result of DKK 587,704 compared with DKK 600,134 the year before. That is an increase of 2.2% compared with the year before. Equity in the 2024 report amounted to DKK 2,911,976. The solvency ratio was 66.4%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,394,727
Profit/Loss
DKK 587,704
Equity
DKK 2,911,976
Total Assets
DKK 4,385,916
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-1.4 mio.588 t.2.9 mio.1
2023-1.4 mio.600 t.2.8 mio.1
2022-987 t.479 t.2.7 mio.1
2021-1.8 mio.934 t.2.9 mio.1
2020-1.5 mio.714 t.2.4 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

JENARK A/S appoints new auditorNov 19, 2024

As of November 19, 2024, RTS Statsautoriseret Revisionsaktieselskab has been appointed auditor of JENARK A/S.

About JENARK A/S

JENARK A/S is a Danish company of the type Aktieselskab based in Helsingør, founded in 1989. The company is registered under the industry Anden teknisk rådgivning. The company was previously named COBIOTEKNIK A/S and ALPHA-BIOTEKNIK A/S. The management consists of Maria Paaskesen. The board consists of Boe Leo Sander Paaskesen (chair), June Paaskesen and Maria Paaskesen. The company is owned by Vibrant Holding AB. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,519,698 and a net result of DKK 602,209 compared with DKK 587,704 the year before. Equity in the 2025 report amounted to DKK 3,214,186.

Source: annual report 2025, Danish Business Authority